Search Results - "Huisman, Eline L"

The long-term cost-effectiveness of oral semaglutide in the Netherlands based on the PIONEER 2, 3 and 4 randomized controlled trials by Malkin, Samuel J.P., Hunt, Barnaby, Huisman, Eline L., Grand, Tobias S., Chubb, Barrie

“…To assess the long-term cost-effectiveness of novel glucagon-like peptide-1 (GLP-1) analog oral semaglutide versus sodium-glucose cotransporter-2 inhibitor…”
Get full text

Evaluating the Clinical and Economic Outcomes Associated with Poor Glycemic Control in People with Type 1 Diabetes in the Netherlands by Moes, Robert Gerald Jan, Huisman, Eline L, Malkin, Samuel J P, Hunt, Barnaby

“…Achieving and maintaining glycemic control is the cornerstone of type 1 diabetes management, with the aim of reducing the incidence of diabetes-related…”
Get full text

Clinical effectiveness of liraglutide vs basal insulin in a real‐world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes by Overbeek, Jetty A., Heintjes, Edith M., Huisman, Eline L., Tikkanen, Christian K., van Diermen, Arnout W., Penning‐van Beest, Fernie J.A., Herings, Ron M.C.

“…Aims To compare real‐world antidiabetic treatment outcomes over 12 months in obese people with type 2 diabetes mellitus (T2DM) who previously received oral…”
Get full text

Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands by Hunt, Barnaby, Malkin, Samuel J P, Moes, Robert G J, Huisman, Eline L, Vandebrouck, Tom, Wolffenbuttel, Bruce H R

“…ObjectiveChoosing therapies for type 2 diabetes that are both effective and cost-effective is vital as healthcare systems worldwide aim to maximize health of…”
Get full text

A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD by Sion, Katya Y. J., Huisman, Eline L., Punekar, Yogesh S., Naya, Ian, Ismaila, Afisi S.

“…Introduction Comparative data on the efficacies of long-acting muscarinic antagonist (LAMA) and long-acting β 2 -agonist (LABA) combinations for the treatment…”
Get full text

Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis by Ismaila, Afisi Segun, Huisman, Eline L, Punekar, Yogesh Suresh, Karabis, Andreas

“…Randomized, controlled trials comparing long-acting muscarinic antagonist (LAMA) efficacy in COPD are limited. This network meta-analysis (NMA) assessed the…”
Get full text

Economic evaluation of pooled solvent/detergent treated plasma versus single donor fresh-frozen plasma in patients receiving plasma transfusions in the United States by Huisman, Eline L, de Silva, Shamika U, de Peuter, Maria A

“…Abstract This study assessed the cost-effectiveness of Octaplas™ versus fresh frozen plasma (FFP) in patients receiving plasma transfusions in the United…”
Get full text

Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis by Huisman, Eline L, Cockle, Sarah M, Ismaila, Afisi S, Karabis, Andreas, Punekar, Yogesh Suresh

“…Several new fixed-dose combination bronchodilators have been recently launched, and assessing their efficacy relative to each other, and with open dual…”
Get full text

Cost-effectiveness and budget impact study of solvent/detergent (SD) treated plasma (octaplasLG® ) versus fresh-frozen plasma (FFP) in any patient receiving transfusion in Canada by Huisman, Eline L, van Eerd, Margreet C, Ouwens, J.N. Mario, de Peuter, Maria A

“…Abstract The objectives of this study were to evaluate the cost-effectiveness and budget impact of octaplasLG® compared with fresh-frozen plasma (FFP) in all…”
Get full text

A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β 2 -Agonist (LABA) Combinations in COPD by Sion, Katya Y J, Huisman, Eline L, Punekar, Yogesh S, Naya, Ian, Ismaila, Afisi S

“…Comparative data on the efficacies of long-acting muscarinic antagonist (LAMA) and long-acting β -agonist (LABA) combinations for the treatment of…”
Get full text